Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.
This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.Professor Ian Shott, executive chair
Business funding insights
BGF explains: initial public offerings (IPOs)
We explain what’s meant by an initial public offering (IPO), also known as listing or ‘going public’.
When to pursue debt refinancing and why
You may find that refinancing or renegotiating your business debts can put you in a stronger financial position. Look at…